Long-Term Effects of Intravitreal Ranibizumab Compared With Panretinal Photocoagulation on Optical Coherence Tomography Measured Choroidal Thickness and Vascularity

Overview

Journal Transl Vis Sci Technol

Specialties Biomedical Engineering
Ophthalmology

Date 2024 Jul 26

PMID 39058503

Authors

Brian Lee

Kristin Josic

Muneeswar G Nittala

Swetha B Velaga

Ayesha Karamat

Sowmya Srinivas

Federico Corvi

Gagan Singh

SriniVas Sadda

Jennifer K Sun

Michael Ip

Affiliations

Soon will be listed here.

Abstract

Purpose: Compare choroidal changes in ranibizumab versus panretinal photocoagulation (PRP)-treated eyes with proliferative diabetic retinopathy (PDR).

Methods: DRCR Retina Network Protocol S post hoc analysis evaluated optical coherence tomography change in choroidal thickness (subfoveal and 3mm superior and inferior to the fovea) through five years; choroidal vascularity index (CVI) was assessed at baseline and one year. Mixed linear models for choroidal change included adjustments for the baseline choroidal value and age.

Results: This study included 328 eyes (158 ranibizumab and 170 PRP) from 256 participants (88 ranibizumab and 95 PRP eyes at five years). Mean change in choroidal thickness from baseline to five years at the fovea was -12 µm in ranibizumab versus -8 µm in PRP (difference [95% confidence interval]: -4 [-18 to 10], P = 0.57), superior was -14 µm versus -19 µm (difference: 5 [-8 to 17], P = 0.45) and inferior was -26 µm versus -32 µm [difference: 5 (-9 to 20), P = 0.45]; change at all three points within the ranibizumab group, and the superior and inferior points for PRP, were statistically significant (P < .05). Mean change in CVI at one year was -0.02% in ranibizumab versus -0.95% in PRP (difference: 0.93 [-0.35 to 2.21], P = 0.14).

Conclusions: In patients with PDR, treatment with ranibizumab versus PRP did not result in statistically significant differences in five-year choroidal thickness or one-year CVI change. Both groups had significant decreases in choroidal thickness at five years.

Translational Relevance: Ranibizumab treatment for PDR did not statistically significantly affect choroidal thickness or vascularity differently than PRP.

References

Regatieri C, Branchini L, Carmody J, Fujimoto J, Duker J . Choroidal thickness in patients with diabetic retinopathy analyzed by spectral-domain optical coherence tomography. Retina. 2012; 32(3):563-8. PMC: 3393081. DOI: 10.1097/IAE.0b013e31822f5678. View

Kim J, Lee D, Joe S, Kim J, Yoon Y . Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients. Invest Ophthalmol Vis Sci. 2013; 54(5):3378-84. DOI: 10.1167/iovs.12-11503. View

Gupta P, Cheng C, Cheung C, Htoon H, Zheng Y, Lamoureux E . Relationship of ocular and systemic factors to the visibility of choroidal-scleral interface using spectral domain optical coherence tomography. Acta Ophthalmol. 2015; 94(2):e142-9. DOI: 10.1111/aos.12777. View

Zhang Z, Meng X, Wu Z, Zou W, Zhang J, Zhu D . Changes in Choroidal Thickness After Panretinal Photocoagulation for Diabetic Retinopathy: A 12-Week Longitudinal Study. Invest Ophthalmol Vis Sci. 2015; 56(4):2631-8. DOI: 10.1167/iovs.14-16226. View

Kung E, Chan V, Tang Z, Yang D, Sun Z, Wang Y . Alterations in the Choroidal Sublayers in Relationship to Severity and Progression of Diabetic Retinopathy: A Swept-Source OCT Study. Ophthalmol Sci. 2022; 2(2):100130. PMC: 9560641. DOI: 10.1016/j.xops.2022.100130. View

Kim M, Ha M, Choi S, Park Y . Choroidal vascularity index in type-2 diabetes analyzed by swept-source optical coherence tomography. Sci Rep. 2018; 8(1):70. PMC: 5758605. DOI: 10.1038/s41598-017-18511-7. View

Russell J, Zhou H, Shi Y, Shen M, Gregori G, Feuer W . LONGITUDINAL ANALYSIS OF DIABETIC CHOROIDOPATHY IN PROLIFERATIVE DIABETIC RETINOPATHY TREATED WITH PANRETINAL PHOTOCOAGULATION USING WIDEFIELD SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY. Retina. 2021; 42(3):417-425. PMC: 8860863. DOI: 10.1097/IAE.0000000000003375. View

FUKUSHIMA I, McLeod D, Lutty G . Intrachoroidal microvascular abnormality: a previously unrecognized form of choroidal neovascularization. Am J Ophthalmol. 1997; 124(4):473-87. DOI: 10.1016/s0002-9394(14)70863-3. View

Zhou H, Dai Y, Shi Y, Russell J, Lyu C, Noorikolouri J . Age-Related Changes in Choroidal Thickness and the Volume of Vessels and Stroma Using Swept-Source OCT and Fully Automated Algorithms. Ophthalmol Retina. 2020; 4(2):204-215. PMC: 7812781. DOI: 10.1016/j.oret.2019.09.012. View

10.

Kim J, Park N . Changes in choroidal vascular parameters following pan-retinal photocoagulation using swept-source optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2019; 258(1):39-47. DOI: 10.1007/s00417-019-04475-z. View

11.

Zhou H, Chu Z, Zhang Q, Dai Y, Gregori G, Rosenfeld P . Attenuation correction assisted automatic segmentation for assessing choroidal thickness and vasculature with swept-source OCT. Biomed Opt Express. 2019; 9(12):6067-6080. PMC: 6490991. DOI: 10.1364/BOE.9.006067. View

12.

Yau J, Rogers S, Kawasaki R, Lamoureux E, Kowalski J, Bek T . Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012; 35(3):556-64. PMC: 3322721. DOI: 10.2337/dc11-1909. View

13.

Kniggendorf V, Novais E, Kniggendorf S, Xavier C, Cole E, Regatieri C . Effect of intravitreal anti-VEGF on choroidal thickness in patients with diabetic macular edema using spectral domain OCT. Arq Bras Oftalmol. 2016; 79(3):155-8. DOI: 10.5935/0004-2749.20160047. View

14.

Velaga S, Nittala M, Vupparaboina K, Jana S, Chhablani J, Haines J . CHOROIDAL VASCULARITY INDEX AND CHOROIDAL THICKNESS IN EYES WITH RETICULAR PSEUDODRUSEN. Retina. 2019; 40(4):612-617. DOI: 10.1097/IAE.0000000000002667. View

15.

Cho G, Cho H, Kim Y . Change in subfoveal choroidal thickness after argon laser panretinal photocoagulation. Int J Ophthalmol. 2013; 6(4):505-9. PMC: 3755312. DOI: 10.3980/j.issn.2222-3959.2013.04.18. View

16.

Lutty G, Cao J, McLeod D . Relationship of polymorphonuclear leukocytes to capillary dropout in the human diabetic choroid. Am J Pathol. 1997; 151(3):707-14. PMC: 1857840. View

17.

Wang D, Velaga S, Grondin C, Au A, Nittala M, Chhablani J . Pentosan Polysulfate Maculopathy: Prevalence, Spectrum of Disease, and Choroidal Imaging Analysis Based on Prospective Screening. Am J Ophthalmol. 2021; 227:125-138. DOI: 10.1016/j.ajo.2021.02.025. View

18.

Shima D, Adamis A, Ferrara N, Yeo K, Yeo T, Allende R . Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med. 1995; 1(2):182-93. PMC: 2229943. View

19.

Agrawal R, Ding J, Sen P, Rousselot A, Chan A, Nivison-Smith L . Exploring choroidal angioarchitecture in health and disease using choroidal vascularity index. Prog Retin Eye Res. 2020; 77:100829. DOI: 10.1016/j.preteyeres.2020.100829. View

20.

Endo H, Kase S, Takahashi M, Saito M, Yokoi M, Sugawara C . Relationship between diabetic macular edema and choroidal layer thickness. PLoS One. 2020; 15(1):e0226630. PMC: 6946145. DOI: 10.1371/journal.pone.0226630. View